This January, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US, according to data from healthcare
The Biden Administration had announced the price cuts that were negotiated by the Centers for Medicare and Medicaid Services (CMS) for the first ten selected
In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act,
The list is mostly unsurprising but contains fewer cancer drugs than most industry experts had predicted. Credit: MargJohnsonVA via Shutterstock. The Biden Administration has released
The companies from the selected drugs will have to sign an agreement with the Centers for Medicare & Medicaid Services to participate in drug price
The new bill would extend the Inflation Reduction Act in three ways. Credit: Africa Studio via Shutterstock. This article is produced as part of GlobalData’s